NR2F6 and neoplasm: In vitro studies revealed NR2F6 acting as inhibitory receptor, highly expressed on so called “exhausted” T cells, as they might be found in tumor tissue due to a tumor-related unregulated T-cell activation process (Wherry and Kurachi 2015; Klepsch et al. 2021).